Who
Jessica Hopfield
Director
Company insider
Files Form 4 as: Director, Editas Medicine; Director, Insulet; Director, Maravai LifeSciences Holdings; Director, Bruker Cellular Analysis; Director, Radius Health.
In numbers
- Trades disclosed
- 57
- Buys
- 9
- Sells
- 2
- Bought
- $3.3M
- Sold
- $3.4M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 27 Jul 2015
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | EDIT Editas Medicineoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code A | —51,700 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | EDIT Editas Medicineoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code A | —51,700 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —1,660 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —1,660 at $0.00 | filing |
| 16 Jun 2025filed 18 Jun 2025 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code A | $193K89,139 at $2.16 | filing |
| 6 Jun 2025filed 10 Jun 2025 | EDIT Editas Medicineoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —778 at $0.00 | filing |
| 13 May 2025filed 14 May 2025 | PODD Insuletoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,235 at $0.00 | filing |
| 13 May 2025filed 14 May 2025 | PODD InsuletMedical Devices | SEC FORM 4 Code M | $151K5,235 at $28.87 | filing |
| 13 May 2025filed 14 May 2025 | PODD InsuletMedical Devices | SEC FORM 4 Sold | $1.7M5,235 at $317.54 | filing |
| 11 Sep 2024filed 12 Sep 2024 | PODD Insuletoption or derivative · Medical Devices | SEC FORM 4 Code M | —7,628 at $0.00 | filing |
| 11 Sep 2024filed 12 Sep 2024 | PODD InsuletMedical Devices | SEC FORM 4 Code M | $228K7,628 at $29.87 | filing |
| 11 Sep 2024filed 12 Sep 2024 | PODD InsuletMedical Devices | SEC FORM 4 Sold | $1.7M7,628 at $225.26 | filing |
| 30 May 2024filed 3 Jun 2024 | EDIT Editas Medicineoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 23 May 2024filed 24 May 2024 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code A | $223K20,645 at $10.78 | filing |
| 22 May 2024filed 23 May 2024 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —1,380 at $0.00 | filing |
| 13 May 2024filed 14 May 2024 | EDIT Editas MedicineGenomics & Gene Editing | SEC FORM 4 Bought | $254K45,000 at $5.64 | filing |
| 2 Oct 2023filed 3 Oct 2023 | Bruker Cellular Analysis | SEC FORM 4 Code M | —74,030 | filing |
| 2 Oct 2023filed 3 Oct 2023 | Bruker Cellular Analysis | SEC FORM 4 Code D | —105,207 | filing |
| 17 Jul 2023filed 19 Jul 2023 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
News
Financial Contrast: Alvotech (NASDAQ:ALVO) & Editas Medicine (NASDAQ:EDIT)EDIT · themarketsdaily.com · 18 Oct 2026Editas Medicine (NASDAQ:EDIT) Raised to Overweight at Wells Fargo & CompanyEDIT · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Jessica Hopfield; 2 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.